VULTAGGIO VINCENT (PAO and PFO) sold 1.4% of their position (2.62K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $4.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2025ACC: 0001725160-25-000043
Officer· PAO and PFO
Since Feb 2026
+191.60K
Net shares
Net buyer
$4.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
194.22K acquired · 2.62K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+158.59K
Price / share
—
Trade value
—
% of position
468.4%
2/3/2025
33.85K→192.44K
Common Stock
Direct
Shares
−2.62K
Price / share
$1.71
Trade value
$4.48K
% of position
1.4%
2/3/2025
192.44K→189.83K
Total
Net shares
+155.97K
Net value
-$4.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2025 | A · Award | +158.59K | — | — | 468.4% | 33.85K | 192.44K |
| Common Stock Direct | 2/3/2025 | S · Sale | −2.62K | $1.71 | $4.48K | 1.4% | 192.44K | 189.83K |
| Total | +155.97K | -$4.48K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
35.63K shares
Shares
+35.63K
Strike price
1.68
Held after
35.63K
Exercisable
—
2/3/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock35.63K shares | 2/3/2025 | A · Award | +35.63K | 1.68 | — | 35.63K |